Surgical Science Sweden AB (SUS) Stock Analysis | Price, Returns, Financials & Key Metrics

Mojo Score Change: Surgical Science Sweden AB has changed its score on 21 Nov 2025. Click here to unlock latest mojo score!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Negative results in Mar 25

OPERATING CASH FLOW(Y) Lowest at SEK 103.78 MM
NET PROFIT(HY) At SEK 88.56 MM has Grown at -27.26%
ROCE(HY) Lowest at 3.11%

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

SEK 3,786 Million (Small Cap)

P/E

39.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.14

Return on Equity

2.59%

Price to Book

0.88

Revenue and Profits:

Net Sales:

209 Million

(Quarterly Results - Jun 2025)

Net Profit:

-20 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-63.0%

6 Months

-76.09%

1 Year

-76.3%

2 Years

-80.21%

3 Years

-77.25%

4 Years

-86.64%

5 Years

-59.13%

Surgical Science Sweden AB for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

53.19%

EBIT Growth (5y)

45.86%

EBIT to Interest (avg)

47.45

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.14

Sales to Capital Employed (avg)

0.20

Tax Ratio

20.05%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

4.57%

ROE (avg)

4.01%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.02

EV to EBIT

25.80

EV to EBITDA

17.42

EV to Capital Employed

1.02

EV to Sales

3.99

PEG Ratio

Dividend Yield

ROCE (Latest)

3.95%

ROE (Latest)

2.59%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

Bullish

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -16.55% vs -0.32% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -160.54% vs -8.54% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "209.20",
          "val2": "250.70",
          "chgp": "-16.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "23.20",
          "val2": "65.80",
          "chgp": "-64.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-26.50",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-20.10",
          "val2": "33.20",
          "chgp": "-160.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.30%",
          "val2": "187.60%",
          "chgp": "-17.33%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.14% vs 10.02% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -43.76% vs 24.47% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "884.10",
          "val2": "882.90",
          "chgp": "0.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "209.90",
          "val2": "246.90",
          "chgp": "-14.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.70",
          "val2": "0.70",
          "chgp": "714.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.30",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "131.60",
          "val2": "234.00",
          "chgp": "-43.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "169.00%",
          "val2": "216.70%",
          "chgp": "-4.77%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

209.20

250.70

-16.55%

Operating Profit (PBDIT) excl Other Income

23.20

65.80

-64.74%

Interest

0.00

Exceptional Items

0.00

-26.50

100.00%

Consolidate Net Profit

-20.10

33.20

-160.54%

Operating Profit Margin (Excl OI)

14.30%

187.60%

-17.33%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is -16.55% vs -0.32% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -160.54% vs -8.54% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

884.10

882.90

0.14%

Operating Profit (PBDIT) excl Other Income

209.90

246.90

-14.99%

Interest

5.70

0.70

714.29%

Exceptional Items

-0.30

0.00

Consolidate Net Profit

131.60

234.00

-43.76%

Operating Profit Margin (Excl OI)

169.00%

216.70%

-4.77%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 0.14% vs 10.02% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -43.76% vs 24.47% in Dec 2023

All Annual Results

Company CV

About Surgical Science Sweden AB

Surgical Science Sweden AB

Pharmaceuticals & Biotechnology

Surgical Science Sweden AB is a Sweden-based company, which provides with virtual reality simulators for evidence based laparoscopic and endoscopic training. The systems comprise LapSim, EndoSim and TeamSim trainings. Each training combine graphics and cognitive instruction, imply navigation on touch screens and feature tactile feedback technology. The LapSim trainings consist of laparoscopic exercises that range from basic navigation to advanced suturing, the EndoSim endoscopic exercises range from functions of the scope handle and tube, to loop reduction. The TeamSim comprises procedure modules to train in a real world operation room environment and helps to build team communication skills in crisis and routine situations. The training systems are used by medical training centers and institutes worldwide for practice, validation and certification of students, surgeons, and medical doctors.

Company Coordinates

Company Details

Drakegatan 7 A, 3 tr. , GOETEBORG None : 412 50

Tel: 46 31 7416560

https://surgicalscience.com/

Registrar Details